{"transactions":[{"id":729203,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T20:59:10.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":6212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2027 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":6212,"derivative":{"exercise_price":70.79,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":6212},"source":{"system":"sec-edgar","filing":"0001193125-26-279712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526279712/ownership.xml","form_type":"4"}},{"id":853268,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":7905,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7905},"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853267,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"sale","planned":false,"acquired":false,"shares":8787,"price":53,"value":465711.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.03. The Reporting Person undertakes to provide to Supernus, any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":27277,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853266,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":7905,"price":25.3,"value":199996.5,"ownership":{"direct":true},"balance_after":36064,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":853265,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:06:53.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":53.71,"value":537100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.50 to $54.15. The Reporting Person undertakes to provide to\nSupernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold\nat each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":28159,"source":{"system":"sec-edgar","filing":"0001256088-26-000006","document":"wk-form4_1773086807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000006/wk-form4_1773086807.xml","form_type":"4"}},{"id":881684,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:36:03.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001256088-26-000004","document":"wk-form4_1772055360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000004/wk-form4_1772055360.xml","form_type":"4"}},{"id":881683,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-02-25T21:36:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001256088-26-000004","document":"wk-form4_1772055360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000004/wk-form4_1772055360.xml","form_type":"4"}},{"id":881682,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T21:36:03.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38159,"source":{"system":"sec-edgar","filing":"0001256088-26-000004","document":"wk-form4_1772055360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000004/wk-form4_1772055360.xml","form_type":"4"}},{"id":881681,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-25T21:36:03.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"balance_after":33684,"source":{"system":"sec-edgar","filing":"0001256088-26-000004","document":"wk-form4_1772055360.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000004/wk-form4_1772055360.xml","form_type":"4"}},{"id":890393,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:12.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":4977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option vests on February 18, 2027."}],"balance_after":4977,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":4977},"source":{"system":"sec-edgar","filing":"0001256088-26-000002","document":"wk-form4_1771623910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000002/wk-form4_1771623910.xml","form_type":"4"}},{"id":890392,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:45:12.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":2989,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 18, 2027."}],"balance_after":2989,"derivative":{"underlying":"Common Stock","underlying_shares":2989},"source":{"system":"sec-edgar","filing":"0001256088-26-000002","document":"wk-form4_1771623910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000125608826000002/wk-form4_1771623910.xml","form_type":"4"}},{"id":1036391,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-18T21:03:37.000Z","date":"2025-09-16","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2026 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":1000,"derivative":{"exercise_price":60.34,"expiration_date":"2035-09-15","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-207557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312525207557/ownership.xml","form_type":"4"}},{"id":1111857,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T21:23:39.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2026 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":50.86,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-086384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025086384/ownership.xml","form_type":"4"}},{"id":1249213,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-02-24T22:45:13.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001628280-25-007463","document":"wk-form4_1740437106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828025007463/wk-form4_1740437106.xml","form_type":"4"}},{"id":1249212,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-24T22:45:13.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18684,"source":{"system":"sec-edgar","filing":"0001628280-25-007463","document":"wk-form4_1740437106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828025007463/wk-form4_1740437106.xml","form_type":"4"}},{"id":1252477,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T21:49:39.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026."}],"balance_after":4475,"derivative":{"underlying":"Common Stock","underlying_shares":4475},"source":{"system":"sec-edgar","filing":"0001628280-25-007186","document":"wk-form4_1740174572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828025007186/wk-form4_1740174572.xml","form_type":"4"}},{"id":1252476,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-02-21T21:49:39.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":7296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 19, 2026."}],"balance_after":7296,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":7296},"source":{"system":"sec-edgar","filing":"0001628280-25-007186","document":"wk-form4_1740174572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828025007186/wk-form4_1740174572.xml","form_type":"4"}},{"id":1368579,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-11-12T21:13:04.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":10787,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.46,"exercise_date":"2016-03-23","expiration_date":"2025-03-23","underlying":"Common Stock","underlying_shares":10787},"source":{"system":"sec-edgar","filing":"0001628280-24-047145","document":"wk-form4_1731445977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024047145/wk-form4_1731445977.xml","form_type":"4"}},{"id":1368578,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T21:13:04.000Z","date":"2024-11-08","kind":"sale","planned":false,"acquired":false,"shares":10787,"price":36.3,"value":391568.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 23, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.01 to $36.57. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001628280-24-047145","document":"wk-form4_1731445977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024047145/wk-form4_1731445977.xml","form_type":"4"}},{"id":1368577,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-12T21:13:04.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":true,"shares":10787,"price":11.46,"value":123619.02,"ownership":{"direct":true},"balance_after":24102,"source":{"system":"sec-edgar","filing":"0001628280-24-047145","document":"wk-form4_1731445977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024047145/wk-form4_1731445977.xml","form_type":"4"}},{"id":1371160,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-11-08T21:11:58.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":false,"shares":14213,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10787,"derivative":{"exercise_price":11.46,"exercise_date":"2016-03-23","expiration_date":"2025-03-23","underlying":"Common Stock","underlying_shares":14213},"source":{"system":"sec-edgar","filing":"0001628280-24-046666","document":"wk-form4_1731100311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024046666/wk-form4_1731100311.xml","form_type":"4"}},{"id":1371159,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T21:11:58.000Z","date":"2024-11-07","kind":"sale","planned":false,"acquired":false,"shares":14213,"price":36.62,"value":520480.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 23, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $36.89. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001628280-24-046666","document":"wk-form4_1731100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024046666/wk-form4_1731100311.xml","form_type":"4"}},{"id":1371158,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-08T21:11:58.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":true,"shares":14213,"price":11.46,"value":162880.98,"ownership":{"direct":true},"balance_after":27528,"source":{"system":"sec-edgar","filing":"0001628280-24-046666","document":"wk-form4_1731100311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024046666/wk-form4_1731100311.xml","form_type":"4"}},{"id":1404832,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-09-17T20:10:48.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":11.46,"exercise_date":"2016-03-23","expiration_date":"2025-03-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-24-040598","document":"wk-form4_1726603841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024040598/wk-form4_1726603841.xml","form_type":"4"}},{"id":1404831,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T20:10:48.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":31.33,"value":313300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.12 to $31.50. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001628280-24-040598","document":"wk-form4_1726603841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024040598/wk-form4_1726603841.xml","form_type":"4"}},{"id":1404830,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T20:10:48.000Z","date":"2024-09-13","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":11.46,"value":114600.0,"ownership":{"direct":true},"balance_after":23315,"source":{"system":"sec-edgar","filing":"0001628280-24-040598","document":"wk-form4_1726603841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024040598/wk-form4_1726603841.xml","form_type":"4"}},{"id":1404829,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T20:10:48.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":3886,"price":31.33,"value":121748.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.12 to $31.50. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. (\"Supernus\"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001628280-24-040598","document":"wk-form4_1726603841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000162828024040598/wk-form4_1726603841.xml","form_type":"4"}},{"id":1479196,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:15:08.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2025 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":38.85,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-073673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024073673/ownership.xml","form_type":"4"}},{"id":1615148,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T22:04:01.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-24-028279","document":"tm247055-17_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465924028279/tm247055-17_4seq1.xml","form_type":"4"}},{"id":1615147,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T22:04:01.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17201,"source":{"system":"sec-edgar","filing":"0001104659-24-028279","document":"tm247055-17_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465924028279/tm247055-17_4seq1.xml","form_type":"4"}},{"id":1618941,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-26T22:03:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."}],"balance_after":5369,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001104659-24-027583","document":"tm247055-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465924027583/tm247055-8_4seq1.xml","form_type":"4"}},{"id":1618940,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-26T22:03:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":8252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 22, 2025."}],"balance_after":8252,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":8252},"source":{"system":"sec-edgar","filing":"0001104659-24-027583","document":"tm247055-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465924027583/tm247055-8_4seq1.xml","form_type":"4"}},{"id":1860803,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T22:24:47.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":7136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2024 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":7136,"derivative":{"exercise_price":45.69,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":7136},"source":{"system":"sec-edgar","filing":"0000899243-23-015271","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924323015271/doc4.xml","form_type":"4"}},{"id":1989906,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T22:01:31.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."}],"balance_after":3886,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-23-026076","document":"tm237737-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465923026076/tm237737-13_4seq1.xml","form_type":"4"}},{"id":1989905,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-02-27T22:01:31.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":6293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 23, 2024."}],"balance_after":6293,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":6293},"source":{"system":"sec-edgar","filing":"0001104659-23-026076","document":"tm237737-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465923026076/tm237737-13_4seq1.xml","form_type":"4"}},{"id":1992682,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-24T22:14:41.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-23-025380","document":"tm237737-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465923025380/tm237737-4_4seq1.xml","form_type":"4"}},{"id":1992681,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T22:14:41.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13315,"source":{"system":"sec-edgar","filing":"0001104659-23-025380","document":"tm237737-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465923025380/tm237737-4_4seq1.xml","form_type":"4"}},{"id":2072808,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-03T22:17:52.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest upon the first to occur of (i) the date of the Company's 2023 annual meeting of its stockholders, or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":7000,"derivative":{"exercise_price":13.5,"expiration_date":"2032-12-28","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-23-000318","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924323000318/doc4.xml","form_type":"4"}},{"id":2374318,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-25T02:22:28.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3882,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-22-026874","document":"tm227622-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465922026874/tm227622-1_4seq1.xml","form_type":"4"}},{"id":2374317,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-02-25T02:22:28.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":6847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6847,"derivative":{"exercise_price":32.2,"exercise_date":"2023-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":6847},"source":{"system":"sec-edgar","filing":"0001104659-22-026874","document":"tm227622-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465922026874/tm227622-1_4seq1.xml","form_type":"4"}},{"id":2377859,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-23T21:17:58.000Z","date":"2022-02-19","kind":"disposition_to_issuer","acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-22-026103","document":"tm227492d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465922026103/tm227492d3_4seq1.xml","form_type":"4"}},{"id":2377858,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-23T21:17:58.000Z","date":"2022-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9433,"source":{"system":"sec-edgar","filing":"0001104659-22-026103","document":"tm227492d3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465922026103/tm227492d3_4seq1.xml","form_type":"4"}},{"id":2444378,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair of the Board"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:04:30.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":793274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the Option Shares shall become exercisable on August 5, 2022 and the remaining 50% of the Option Shares shall become exercisable on August 5, 2023."}],"balance_after":793274,"derivative":{"exercise_price":3.08,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":793274},"source":{"system":"sec-edgar","filing":"0001209191-22-001628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000120919122001628/doc4.xml","form_type":"4"}},{"id":2510919,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-16T12:56:41.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":17245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the option shall vest on the earlier of (a) the one-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date."}],"balance_after":17245,"derivative":{"exercise_price":3.58,"expiration_date":"2031-11-14","underlying":"Common Stock","underlying_shares":17245},"source":{"system":"sec-edgar","filing":"0000899243-21-044718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924321044718/doc4.xml","form_type":"4"}},{"id":2510918,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-16T12:56:41.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":23514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option shall vest on August 5, 2022 so long as the Optionee continues to have a Service Relationship with the Company on such date."}],"balance_after":23514,"derivative":{"exercise_price":3.58,"expiration_date":"2031-11-14","underlying":"Common Stock","underlying_shares":23514},"source":{"system":"sec-edgar","filing":"0000899243-21-044718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000089924321044718/doc4.xml","form_type":"4"}},{"id":2733152,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T20:02:43.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":45466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of three years from the Vesting Start Date, April 29, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting in eight quarterly installments thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company."}],"balance_after":45466,"derivative":{"exercise_price":11.92,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":45466},"source":{"system":"sec-edgar","filing":"0001213900-21-024226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000121390021024226/ownership.xml","form_type":"4"}},{"id":2838700,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-23T23:48:31.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."}],"balance_after":4222,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-21-026929","document":"tm217706-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465921026929/tm217706-4_4seq1.xml","form_type":"4"}},{"id":2838699,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-02-23T23:48:31.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7365,"derivative":{"exercise_price":29.61,"exercise_date":"2022-02-19","expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001104659-21-026929","document":"tm217706-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465921026929/tm217706-4_4seq1.xml","form_type":"4"}},{"id":3018373,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3018372,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3018371,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":8855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3018370,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":11207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3018369,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":14.84,"expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3018368,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T17:12:58.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":14090,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the \"Merger Agreement\"), by and among Johnson & Johnson, Vigor Sub, Inc. (\"Merger Sub\") and the Issuer, including the completion of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $52.50 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Merger Sub on October 1, 2020.  Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-010060","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020010060/edgar.xml","form_type":"4"}},{"id":3064585,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-07T16:48:40.000Z","date":"2020-08-05","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"}],"balance_after":10000,"derivative":{"exercise_price":14.84,"exercise_date":"2018-01-01","expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-008797","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008797/edgar.xml","form_type":"4"}},{"id":3064584,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T16:48:40.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":10000,"price":33,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"}],"balance_after":14090,"source":{"system":"sec-edgar","filing":"0001179110-20-008797","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008797/edgar.xml","form_type":"4"}},{"id":3064583,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-07T16:48:40.000Z","date":"2020-08-05","kind":"exercise","acquired":true,"shares":10000,"price":14.84,"value":148400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"}],"balance_after":24090,"source":{"system":"sec-edgar","filing":"0001179110-20-008797","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008797/edgar.xml","form_type":"4"}},{"id":3073284,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-30T19:03:31.000Z","date":"2020-07-29","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"}],"balance_after":20000,"derivative":{"exercise_price":14.84,"exercise_date":"2017-01-01","expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-008586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008586/edgar.xml","form_type":"4"}},{"id":3073283,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-30T19:03:31.000Z","date":"2020-07-29","kind":"sale","acquired":false,"shares":10000,"price":30,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":14090,"source":{"system":"sec-edgar","filing":"0001179110-20-008586","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008586/edgar.xml","form_type":"4"}},{"id":3073282,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-30T19:03:31.000Z","date":"2020-07-29","kind":"exercise","acquired":true,"shares":10000,"price":14.84,"value":148400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 28, 2020"}],"balance_after":24090,"source":{"system":"sec-edgar","filing":"0001179110-20-008586","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020008586/edgar.xml","form_type":"4"}},{"id":3100737,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:46:38.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-007756","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911020007756/edgar.xml","form_type":"4"}},{"id":3248707,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-02-25T22:24:45.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":9305,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9305,"derivative":{"exercise_price":23.99,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":9305},"source":{"system":"sec-edgar","filing":"0001104659-20-024851","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465920024851/a4.xml","form_type":"4"}},{"id":3248706,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T22:24:45.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":5211,"price":23.99,"value":125011.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit component of the annual equity compensation to directors.  These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021.  Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."}],"balance_after":5211,"source":{"system":"sec-edgar","filing":"0001104659-20-024851","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465920024851/a4.xml","form_type":"4"}},{"id":3481110,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-21T16:16:04.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-19-008024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008024/edgar.xml","form_type":"4"}},{"id":3481109,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T16:16:04.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-19-008024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008024/edgar.xml","form_type":"4"}},{"id":3481108,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T16:16:04.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14090,"source":{"system":"sec-edgar","filing":"0001179110-19-008024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911019008024/edgar.xml","form_type":"4"}},{"id":3631492,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-27T00:25:46.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":12427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12427,"derivative":{"exercise_price":36.75,"exercise_date":"2020-02-22","expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001104659-19-010797","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465919010797/a4.xml","form_type":"4"}},{"id":3884816,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-22T18:00:05.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-18-008969","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018008969/edgar.xml","form_type":"4"}},{"id":3884815,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-22T18:00:05.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":4356,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-18-008969","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018008969/edgar.xml","form_type":"4"}},{"id":3884814,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T18:00:05.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":8855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":8855,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-18-008969","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018008969/edgar.xml","form_type":"4"}},{"id":3884813,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T18:00:05.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9734,"source":{"system":"sec-edgar","filing":"0001179110-18-008969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911018008969/edgar.xml","form_type":"4"}},{"id":4029759,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-02-27T22:44:51.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":8613,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8613,"derivative":{"exercise_price":39.4,"exercise_date":"2019-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":8613},"source":{"system":"sec-edgar","filing":"0001104659-18-012890","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465918012890/a4.xml","form_type":"4"}},{"id":4170032,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:06:49.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":17000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-059626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000120919117059626/doc4.xml","form_type":"4"}},{"id":4170031,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:06:49.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":32069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.08,"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":32069},"source":{"system":"sec-edgar","filing":"0001209191-17-059626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000120919117059626/doc4.xml","form_type":"4"}},{"id":4170030,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:06:49.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":44474,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning July 15, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning July 15, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."}],"balance_after":0,"derivative":{"exercise_price":4.85,"expiration_date":"2025-08-11","underlying":"Common Stock","underlying_shares":44474},"source":{"system":"sec-edgar","filing":"0001209191-17-059626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000120919117059626/doc4.xml","form_type":"4"}},{"id":4274391,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-22T16:09:22.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":5734,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-17-009450","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911017009450/edgar.xml","form_type":"4"}},{"id":4274390,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T16:09:22.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":11207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gemayel's continued service to the Company."}],"balance_after":11207,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-17-009450","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235010/000117911017009450/edgar.xml","form_type":"4"}},{"id":4280467,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-06-15T20:41:08.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":6036,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6036,"derivative":{"exercise_price":38.6,"exercise_date":"2018-06-13","expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":6036},"source":{"system":"sec-edgar","filing":"0001104659-17-039589","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465917039589/a4.xml","form_type":"4"}},{"id":4302700,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T20:32:24.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board."}],"balance_after":17000,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-035842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000120919117035842/doc4.xml","form_type":"4"}},{"id":4420961,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-02-28T02:56:41.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":7905,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7905,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7905},"source":{"system":"sec-edgar","filing":"0001104659-17-012172","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1256088/000110465917012172/a4.xml","form_type":"4"}},{"id":4574171,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-26T16:43:13.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":7915,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding stock option was accelerated in full and cancelled in exchange for the right to receive $9.00 in cash, without interest and less the exercise price of such option and any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":5.22,"expiration_date":"2026-04-15","underlying":"Common Stock","underlying_shares":7915},"source":{"system":"sec-edgar","filing":"0001140361-16-083654","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083654/doc1.xml","form_type":"4"}},{"id":4574170,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-26T16:43:13.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":8330,"price":9,"value":74970.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on October 25, 2016, each outstanding restricted stock unit was accelerated in full and cancelled in exchange for the right to receive $9.00 per share in cash, without interest and less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-16-083654","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083654/doc1.xml","form_type":"4"}},{"id":4574169,"issuer":{"id":181476,"kind":"organization","name":"Raptor Pharmaceutical Corp","symbol":"RPTP"},"owners":[{"id":36003,"kind":"person","name":"GEMAYEL GEORGES","position":1,"cik":"0001256088","reported_name":"GEMAYEL GEORGES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-26T16:43:13.000Z","date":"2016-10-24","kind":"other","acquired":false,"shares":2092,"price":9,"value":18828.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares tendered in connection with an offer to purchase all of the issued and outstanding shares of common stock of Raptor Pharmaceutical Corp. (\"Raptor\"), par value $0.001 per share, for an amount of $9.00 per share in cash, without interest and less any applicable withholding taxes, commenced pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of September 12, 2016, by and among Raptor, Horizon Pharma plc, a public limited company organized under the laws of Ireland (\"Parent\") and Misneach Corporation, a Delaware corporation and an indirect wholly owned subsidiary of Parent."}],"balance_after":8330,"source":{"system":"sec-edgar","filing":"0001140361-16-083654","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070698/000114036116083654/doc1.xml","form_type":"4"}}]}